Skip to main content
. 2010 Mar 11;10:93. doi: 10.1186/1471-2407-10-93

Figure 2.

Figure 2

Study Design. 489 unselected patients were initially entered into this study. After tissue microarray construction, immunohistochemistry for VEGF ligands and receptors, 102 mismatch repair-deficient cases were excluded. Analysis of VEGF ligand/receptor ratio with clinico-pathological features and survival was performed on the remaining 387 mismatch repair-proficient cases.